NVCR
NovoCure Ltd · Healthcare · Market cap $2.1B
Insiders sold $893K net in the last 90 days ·7 sellers, 0 buyers· latest Form 4 filed Jun 5, 2026
Insider Buying
$997K
reported purchases (SEC code P)
Insider Selling
$3.2M
reported sales (SEC code S)
Unique Insiders
14
in the rolling window
Latest filing
Jul 1, 2026
Leonard Frank X
NovoCure Ltd (NVCR) has 42 SEC Form 4 filings (60 transaction rows) in the rolling window, disclosed by 14 distinct insiders. Most recent filing: Jul 1, 2026.
Inside the rolling window, 14 insiders at NovoCure Ltd reported 1 open-market purchase totaling $997K and 23 open-market sales totaling $3.2M. The most active filer is Chief Executive Officer Leonard Frank X with 4 filings. Insiders have net sold $3.2M over the trailing 6 months. The most recent open-market filing is a sale of 34,273 shares by Chief Executive Officer Leonard Frank X, dated Jun 4, 2026, worth $615K.
- Industry:Medical - Devices
- CEO:Frank Leonard
- Employees:1,605
- HQ:Baar, CH
- IPO:2015-10-02
| Source | |||||||
|---|---|---|---|---|---|---|---|
Leonard Frank XFirst in 3 months | Chief Executive Officer | Sale | 34,273 | $615K | Jun 5 | +4.5% | SEC ↗ |
LEUNG GABRIELFirst filing | Director | Sale | 2,945 | $46K | Jun 3 | +11.1% | SEC ↗ |
Stafford KristinFirst filing | Director | Sale | 2,945 | $46K | Jun 3 | +11.1% | SEC ↗ |
Ocean Allyson JFirst filing | Director | Sale | 2,945 | $46K | Jun 3 | +11.1% | SEC ↗ |
VERNON W ANTHONYFirst filing | Director | Sale | 2,945 | $46K | Jun 3 | +11.1% | SEC ↗ |
Scannell Timothy JFirst filing | Director | Sale | 2,945 | $46K | Jun 3 | +11.1% | SEC ↗ |
Hung DavidFirst filing | Director | Sale | 2,945 | $46K | Jun 3 | +11.1% | SEC ↗ |
| Chief Operating Officer | Sale | 5,377 | $72K | Mar 5 | +26.1% | SEC ↗ | |
| Chief Operating Officer | Sale | 43,246 | $596K | Mar 5 | +26.1% | SEC ↗ | |
DOYLE WILLIAM FFirst filing | Executive Chairman | Sale | 71,887 | $933K | Mar 5 | +26.1% | SEC ↗ |
Brackmann ChristophFirst filing | Chief Financial Officer | Sale | 6,412 | $85K | Mar 5 | — | SEC ↗ |
| Chief Human Resources Officer | Sale | 1,100 | $15K | Mar 5 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 5,607 | $75K | Mar 5 | — | SEC ↗ | |
| Chf Medical and Innovation Ofr | Sale | 6,412 | $85K | Mar 5 | — | SEC ↗ | |
| Former Chief Medical Officer | Sale | 1,100 | $15K | Mar 5 | — | SEC ↗ | |
Weinberg UriFirst filing | Chf Medical and Innovation Ofr | Sale | 7,461 | $103K | Mar 3 | — | SEC ↗ |
Weinberg UriFirst filing | Chf Medical and Innovation Ofr | Sale | 3,272 | $44K | Mar 3 | — | SEC ↗ |
Leonard Frank XFirst filing | Chief Executive Officer | Sale | 9,734 | $133K | Mar 3 | — | SEC ↗ |
Leonard Frank XFirst filing | Chief Executive Officer | Sale | 7,232 | $98K | Mar 3 | — | SEC ↗ |
Paravasthu MukundFirst filing | Chief Operating Officer | Sale | 1,555 | $21K | Mar 3 | — | SEC ↗ |
Paravasthu MukundFirst filing | Chief Operating Officer | Sale | 408 | $6K | Mar 3 | — | SEC ↗ |
Leupin NicolasFirst filing | Former Chief Medical Officer | Sale | 1,029 | $14K | Mar 3 | — | SEC ↗ |
Puri Michal NathFirst filing | Chief Human Resources Officer | Sale | 1,441 | $20K | Mar 3 | — | SEC ↗ |
Cordova AshleyFirst filing | Chief Executive Officer | Purchase | 81,550 | $997K | Sep 8 | — | SEC ↗ |
Congress trading NVCR 4 all-time
- DRep. Ro KhannaPurchase$1,001 - $15,0002022-02-14
- DRep. Marie NewmanPurchase$15,001 - $50,0002021-07-02
- DRep. Donna ShalalaOther$1,001 - $15,0002019-06-24
- DRep. Donna ShalalaPurchase$1,001 - $15,0002019-06-19
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Frequently asked questions
How many SEC Form 4 insider filings does NVCR have?
NovoCure Ltd (NVCR) has 42 SEC Form 4 filings (60 transaction rows) in the rolling 365-day window, disclosed by 14 distinct insiders. Most recent filing: Jul 1, 2026.
When was the most recent SEC Form 4 filing for NVCR?
The most recent Form 4 filing for NVCR on Tracefour is dated Jul 1, 2026.
Who is the most active insider at NVCR?
The most active SEC Form 4 filer at NVCR in the rolling window is Chief Executive Officer Leonard Frank X, with 4 filings.
What is the net insider flow at NVCR over the last 6 months?
Over the trailing 180 days, insiders at NVCR have net sold $3.2M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at NVCR in the current window?
Inside the rolling window, insiders at NVCR bought $997K and sold $3.2M based on SEC Form 4 filings.
Can I get alerts for NVCR insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at NovoCure Ltd (NVCR). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
NovoCure Ltd is in the Healthcare sector.